{"database": "openregs", "table": "documents", "rows": [["FDA-2015-N-0030-8509", "FDA", "FDA-2015-N-0030", "Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act", "Notice", "60 Day Proposed Information Collection", "2022-06-17T04:00:00Z", 2022, 6, "2022-06-17T04:00:00Z", "2022-08-17T03:59:59Z", "2022-09-19T19:18:53Z", "2022-13068", 0, 0, "0900006485178b8f"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-N-0030-8509"], "units": {}, "query_ms": 61.86850101221353, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}